LIF insider files Form 4: 7,930 shares exercised at $11.18 and sold at $84.13
Rhea-AI Filing Summary
Charles J. Prober, a director of Life360, Inc. (LIF), reported routine insider transactions executed under a pre-established Rule 10b5-1 trading plan adopted March 14, 2025. On 08/13/2025 the filing shows a stock option exercise/acquisition of 7,930 shares at an exercise price of $11.18, which increased his beneficial ownership to 113,386 shares (this total includes 2,714 restricted stock units). The same day the plan shows the sale of 7,930 shares at $84.13, leaving him with 105,456 shares beneficially owned following the reported transactions. The Form 4 is signed by an attorney-in-fact on 08/15/2025.
Positive
- Transactions executed under a documented Rule 10b5-1 plan, adopted March 14, 2025, supporting pre-established trading intent
- Option exercise at $11.18 demonstrates insider converted compensation into shares before sale
- Filing discloses RSUs (2,714) and vesting schedule, improving transparency about outstanding compensation
Negative
- Insider sale of 7,930 shares at $84.13 on 08/13/2025 reduced beneficial ownership to 105,456 shares
Insights
TL;DR: Director exercised options at $11.18 and sold the resulting shares via a 10b5-1 plan at $84.13 on 08/13/2025.
The filing documents a concurrent exercise of a stock option and an automatic sale under a Rule 10b5-1 plan. Exercising at $11.18 and immediately selling at $84.13 suggests the transactions were mechanical under the pre-set plan rather than opportunistic market-timing by the insider. The report also discloses 2,714 restricted stock units included in the beneficial ownership total, and the option’s vesting schedule is described in the filing. For investors, this is a routine Section 16 disclosure of insider liquidity and option exercise activity.
TL;DR: Transaction executed under documented 10b5-1 plan; reporting meets Section 16 disclosure norms.
The disclosure explicitly states the trades were effected pursuant to a Rule 10b5-1 plan adopted while the reporting person was not aware of material nonpublic information, which supports the affirmative defense. The form includes clear counts of shares before and after the transactions and notes restricted stock units and option vesting terms. This filing is procedural and consistent with established insider trading policies.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 7,930 | $0.00 | -- |
| Exercise | Common stock | 7,930 | $11.18 | $89K |
| Sale | Common stock | 7,930 | $84.13 | $667K |
Footnotes (1)
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 2,714 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 12, 2024 and thereafter vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
